Blog - Datapharm Australia (3)

Pharmacokinetics analysis series: Compartmental analysis

Compartmental analysis (CA) is a type of pharmacokinetics (PK) analysis and is less common than non-compartmental analysis. It uses individual PK data to fit a statistical model across all subjects,...

Pharmacokinetics analysis series: Non-compartmental analysis

Non-compartmental analysis (NCA) is a type of pharmacokinetics (PK) analysis and is the most commonly used approach for establishing initial exposure characteristics for a drug prior to its...

Pharmacokinetics analysis: An overview

Pharmacokinetics (PK) analysis is the study of the time course of drug concentration. It summarises the movement of drugs through the body and what the body does to a given drug over time.

Sample size calculations

What sample size to useis a question commonly asked of Datapharm. The answer requires a collaborative approach as it depends on many factors, both theoretical and practical. To ensure that your...

Datapharm in the Community - The Port Macquarie Koala Hospital

With a very professional-looking Koala as our mascot, Datapharm is passionate in supporting The Port Macquarie Koala Hospital and their efforts through adopting koalas. The Port Macquarie Koala...

Shake It Up with Datapharm Australia on World Parkinson's Day

Did you know that April is World Parkinson's Awareness Month? Moreover, April 11th is World Parkinson's Day. As one of Datapharm Australia’s AustralianClinicalTrials.com initiatives, we are proud to...

How many people do you need? Designing the foundations of a clinical trial

From the outset, designing a trial must take your end goal into consideration. If the trial design, number of subjects, or data collected is not compatible with the type of planned statistical...

The Australian Advantage: Benefits of Running Clinical Research Down Under

Australia has fast established itself as a high-quality, clinical trial friendly location. Even a small amount of research will immediately reveal the many advantages that Australia provides, in such...

#Clinfluencers: Clinical Trial Sponsor Legal Entity Setup in Australia

Australia is home to some of the best researchers and health professionals worldwide. This, coupled with its high standards in health infrastructure, makes it one of the most inviting places in the...

The Australian Tour: Phase I Clinical Trial Units

There are many benefits for companies conducting Phase I research in Australia: you may have already read our previous blog or recently-developed ebook, which deals more generally with the advantages...

Connect with Datapharm at BIO digital 2020

Datapharm will be attending BIO2020 Digital – get in touch if you are interested in catching up via the one-on-one partnering! When collaboration is more

Don’t flatten the (productivity) curve: A blog on getting studies done from home

Currently, there’s an overload of (sometimes conflicting) information regarding how best to carry out clinical trials while working from home. Furthermore, as we cannot be certain when/if...